# Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

> **NCT00088946** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 17 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Polyphenon E
- **DRUG:** erlotinib hydrochloride
- **OTHER:** Erlotinib placebo
- **OTHER:** Polyphenon E

## Key facts

- **NCT ID:** NCT00088946
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00088946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00088946, "Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00088946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*